Comparing Izervay vs Vabysmo
| Izervay (avacincaptad pegol) | Vabysmo (faricimab) |
|
|---|
| Izervay (avacincaptad pegol) | Vabysmo (faricimab) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Geographic Atrophy, Macular Degeneration. Izervay may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Macular Edema, Macular Edema Following Retinal Vein Occlusion, Diabetic Macular Edema, Macular Degeneration. Vabysmo may also be used for purposes not listed in this medication guide. |
Related suggestions Macular Degeneration
|
|||||||||||||||
| More about Izervay (avacincaptad pegol) | More about Vabysmo (faricimab) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Izervay has an average rating of 9.0 out of 10 from a total of 4 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 0% reported a negative effect. |
Vabysmo has an average rating of 7.7 out of 10 from a total of 35 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 6% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Izervay side effects |
View all Vabysmo side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
N/A |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Izervay prices |
View all Vabysmo prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
288 hours |
180 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
N/A |
January 28, 2022 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Ahzantive
Ahzantive (aflibercept-mrbb) is a biosimilar to Eylea that may be used to treat the following eye ...
Beovu
Beovu (brolucizumab-dbll) injection is a biological drug that is used to treat two chronic eye ...
Syfovre
Syfovre (pegcetacoplan) treatment for geographic atrophy (GA) a form of dry age-related macular ...
Byooviz
Byooviz injection is used to treat types of macular degeneration, macular edema and mCNV. Byooviz ...
Cimerli
Cimerli (ranibizumab-eqrn) is an interchangeable biosimilar to Lucentis for the treatment of ...
Enzeevu
Enzeevu is an injectable eye preparation used to treat neovascular (wet) age-related macular ...
Eylea
Eylea is used to treat neovascular (wet) age-related macular degeneration (AMD), macular edema ...
Eylea HD
Eylea HD is used to treat neovascular (wet) age-related macular degeneration (AMD), diabetic ...
Lucentis
Lucentis is used to treat the wet form of age-related macular degeneration. Learn about side ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.